Keyphrases
Clozapine
100%
Patients with Schizophrenia
100%
Hong Kong
100%
Infection Risk
100%
Population-based Cohort Study
100%
Olanzapine
72%
Antipsychotics
27%
Hazard Ratio
27%
Incidence Rate
27%
Absolute Difference
27%
Infectious Diseases
18%
Schizophrenia
18%
ICD-9
18%
Chemical Structure
9%
Therapeutic Benefits
9%
Infection Rate
9%
Monitoring Strategy
9%
Infection Control Measures
9%
Preventive Strategies
9%
Selection Criteria
9%
Natural Causes
9%
Electronic Health Records
9%
Old Age
9%
Causes of Mortality
9%
Increased Incidence
9%
Score-based
9%
People with Lived Experience
9%
Propensity Score
9%
Cox Proportional Hazards Model
9%
Washout Period
9%
Antipsychotic Use
9%
Gastrointestinal Infection
9%
Regular Monitoring
9%
Infection Infection
9%
Inverse Probability of Treatment Weighting
9%
Hospital Authority
9%
Chinese Translation
9%
Upper Respiratory Tract Infection
9%
Schizophrenia Diagnosis
9%
Treatment Resistance
9%
Lower Respiratory Tract Infection
9%
Medicine and Dentistry
Infection
100%
Cohort Analysis
100%
Clozapine
100%
Olanzapine
72%
Hazard Ratio
27%
Antipsychotic
18%
ICD-9-CM
18%
Infectious Disease
9%
Clinician
9%
Infection Control
9%
Proportional Hazards Model
9%
Personal Experience
9%
Diagnosis of Schizophrenia
9%
Electronic Health Record
9%
Gastrointestinal Infection
9%
Primary Outcome
9%
Lower Respiratory Tract Infection
9%
Upper Respiratory Tract Infection
9%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Clozapine
100%
Cohort Study
100%
Olanzapine
72%
Antipsychotic
18%
ICD-9-CM
18%
Lower Respiratory Tract Infection
9%
Diseases
9%
Gastrointestinal Infection
9%
Upper Respiratory Tract Infection
9%
Neuroscience
Clozapine
100%
Olanzapine
72%
Antipsychotic
18%
Lower Respiratory Tract
9%
Upper Respiratory Tract
9%